NCT01849744 Phase I Dose Escalation Study of VS-4718 in Subjects With Metastatic Non-Hematologic Malignancies Status TERMINATED Phase PHASE1
NCT01660360 Phase I Trial of Tanibirumab in Advanced or Metastatic Cancer Status COMPLETED Phase PHASE1
NCT01632436 Pharmacokinetic and Safety Study of Pixantrone in Patients With Metastatic Cancer and Hepatic Impairment Status WITHDRAWN Phase PHASE1
NCT01585415 Vemurafenib and White Blood Cell Therapy for Advanced Melanoma Status TERMINATED Phase PHASE1
NCT01525745 Randomized Study of Stereotactic Body Radiotherapy vs. Conventional Radiation for Spine Metastasis Status TERMINATED Phase PHASE2
NCT01514877 Icotinib Combined With Whole Brain Radiotherapy in Treating Multiple Brain Metastases From Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT01505153 Phase I Intratumoral Pbi-shRNA STMN1 LP in Advanced and/or Metastatic Cancer Status COMPLETED Phase PHASE1
NCT01457131 Modified White Blood Cells That Secrete IL-2 and Express a Protein That Targets the ESO-1tumor Protein for Metastatic Cancer Status TERMINATED Phase PHASE1
NCT01372774 Stereotactic Radiosurgery or Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases That Have Been Removed By Surgery Status COMPLETED Phase PHASE3
NCT01369992 Molecular Profiling of Metastatic Cancer in Pleural Effusion and Ascites Status UNKNOWN Phase N/A
NCT01358110 Emergency Department-Based Palliative Care for Advanced Cancer Patients Status COMPLETED Phase NA
NCT01348048 A Trial Investigating the Effect of Specialised Palliative Care on Symptoms, Survival, Economical Factors and Satisfaction Status COMPLETED Phase PHASE4
NCT01327612 Open Label Extension Study of Conatumumab and Ganitumab (AMG 479) Status COMPLETED Phase PHASE2
NCT01316822 A Study of ARRY-382 in Patients With Selected Advanced or Metastatic Cancers Status COMPLETED Phase PHASE1
NCT01302808 Romidepsin and Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE1
NCT01300533 A Study of BIND-014 Given to Patients With Advanced or Metastatic Cancer Status COMPLETED Phase PHASE1
NCT01278758 A Dose-escalation Pharmacokinetic Study of Intravenous ASA404 in Adult Advanced Cancer Patients With Impaired Renal Function and Patients With Normal Renal Function Status TERMINATED Phase PHASE1
NCT01273181 MAGE-A3/12 Metastatic Cancer Treatment With Anti-MAGE-A3/12 TCR-Gene Engineered Lymphocytes Status TERMINATED Phase PHASE1/PHASE2